Scarpignato C - Search Results

1

Letter: can the overall gastrointestinal safety of celecoxib be extended to all COX-2-selective agents?

Scarpignato C, Blandizzi C. Scarpignato C, et al. Aliment Pharmacol Ther. 2018 Jul;48(1):108-110. doi: 10.1111/apt.14810. Aliment Pharmacol Ther. 2018. PMID: 29882981 No abstract available.

2

Review article: the opportunities and benefits of extended acid suppression.

Scarpignato C, Pelosini I. Scarpignato C, et al. Aliment Pharmacol Ther. 2006 Jun;23 Suppl 2:23-34. doi: 10.1111/j.1365-2036.2006.02945.x. Aliment Pharmacol Ther. 2006. PMID: 16700900 Free article. Review.

3

Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing.

Colucci R, Antonioli L, Bernardini N, Ippolito C, Segnani C, Awwad O, Tuccori M, Blandizzi C, Scarpignato C, Fornai M. Colucci R, et al. Among authors: scarpignato c. J Pharmacol Exp Ther. 2012 Jul;342(1):140-9. doi: 10.1124/jpet.111.190116. Epub 2012 Apr 10. J Pharmacol Exp Ther. 2012. PMID: 22495067 Free article.

4

NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same?

Fornai M, Antonioli L, Colucci R, Pellegrini C, Giustarini G, Testai L, Martelli A, Matarangasi A, Natale G, Calderone V, Tuccori M, Scarpignato C, Blandizzi C. Fornai M, et al. Among authors: scarpignato c. J Pharmacol Exp Ther. 2014 Jan;348(1):86-95. doi: 10.1124/jpet.113.207118. Epub 2013 Oct 17. J Pharmacol Exp Ther. 2014. PMID: 24135073

5

Commentary: Towards an effective and safe treatment of small intestine bacterial overgrowth.

Scarpignato C, Gatta L. Scarpignato C, et al. Aliment Pharmacol Ther. 2013 Dec;38(11-12):1409-10. doi: 10.1111/apt.12531. Aliment Pharmacol Ther. 2013. PMID: 24206376 Free article. No abstract available.

6

Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats.

Antonioli L, Fornai M, Awwad O, Giustarini G, Pellegrini C, Tuccori M, Caputi V, Qesari M, Castagliuolo I, Brun P, Giron MC, Scarpignato C, Blandizzi C, Colucci R. Antonioli L, et al. Among authors: scarpignato c. Br J Pharmacol. 2014 Mar;171(5):1314-29. doi: 10.1111/bph.12539. Br J Pharmacol. 2014. PMID: 24286264 Free PMC article.

7

Is generic rifaximin still a poorly absorbed antibiotic? A comparison of branded and generic formulations in healthy volunteers.

Blandizzi C, Viscomi GC, Marzo A, Scarpignato C. Blandizzi C, et al. Among authors: scarpignato c. Pharmacol Res. 2014 Jul;85:39-44. doi: 10.1016/j.phrs.2014.05.001. Epub 2014 May 14. Pharmacol Res. 2014. PMID: 24836868 Clinical Trial.

8

Editorial: adequate management may reduce the colorectal cancer risk associated with constipation.

Scarpignato C, Blandizzi C. Scarpignato C, et al. Aliment Pharmacol Ther. 2014 Sep;40(5):562-4. doi: 10.1111/apt.12851. Aliment Pharmacol Ther. 2014. PMID: 25103347 Free article. No abstract available.

9

Editorial: hyponatremia - a possible but forgotten consequence of bowel preparation for colonoscopy.

Scarpignato C, Blandizzi C. Scarpignato C, et al. Aliment Pharmacol Ther. 2014 Nov;40(9):1110-2. doi: 10.1111/apt.12917. Aliment Pharmacol Ther. 2014. PMID: 25280254 Free article. No abstract available.

10

Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats.

Antonioli L, Giron MC, Colucci R, Pellegrini C, Sacco D, Caputi V, Orso G, Tuccori M, Scarpignato C, Blandizzi C, Fornai M. Antonioli L, et al. Among authors: scarpignato c. PLoS One. 2014 Dec 30;9(12):e116253. doi: 10.1371/journal.pone.0116253. eCollection 2014. PLoS One. 2014. PMID: 25549098 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

265 results

Search Page

Filters